World Regenerative Medicine Market Reviewed in New RNCOS E-Services Report Published at

13 Dec 2011 • by Natalie Aster
World Regenerative Medicine Market Reviewed in New RNCOS E-Services Report Published at

LONDON – Regenerative medicine is touted as the next-generation technology to revolutionize the medical system of the future. At present, a lot of regenerative medicine technologies are in the developmental stage and approaching commercialization stage. The market was estimated at USD 7.2 billion last year and is poised for rapid development in the forthcoming years.

Major factors driving this market growth include the existence of a host of affected people with degenerative diseases, rise in the global aging population (with further growth in the US and Japan), and the entry of innovative technologies at the marketplace. Life-threatening diseases, such as cancer and diabetes are the key factors fuelling future growth in these countries.

New market research report “Global Regenerative Medicine Market” developed by RNCOS E-Services has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Regenerative Medicine Market
Published: December, 2011
Pages: 105
Price: US$ 1,200

The report provides an all-encompassing overview of the world regenerative medicine market, comprehensively investigating the important characteristics as well as giving true insights into the competitive landscape of the industry. In addition, future outlook for the market and its core segments can also be found in the study.

Report Contents:

1. Analyst View

2. Research Methodology

3. Regenerative Medicine: Introduction
3.1 Tissue Engineering
3.2 Stem Cell Therapy

4. Industry Characteristics
4.1 R&D: Huge Investments Leading to Product Innovations
4.2 Companies Garnering Success through Collaborations
4.3 Presence of Cut Throat Competition Intensifying Private Sector Participation
4.4 Aging Population Worldwide to Boost Industry

5. Industry Performance
5.1 Current Market Overview and Future Outlook to 2014
5.2 Key Industry Segments
  5.2.1 Tissue Engineered Products
  5.2.2 Cell Therapy Market

6. Application Areas for Regenerative Medicine
6.1 Cardiovascular Diseases
6.2 Diabetes
6.3 Cancer
6.4 CNS Diseases
6.5 Eye Diseases

7. Key Geographical Market
7.1 US
7.2 Europe
7.3 Asia-Pacific
  7.3.1 Japan
  7.3.2 China
  7.3.3 India

8. Pipeline Analysis

9. Competitive Assessment
9.1 Aastrom Biosciences, Inc.
9.2 Advanced Cell Technology, Inc.
9.3 Athersys, Inc
9.4 Amgen, Inc.
9.5 Bioheart, Inc.
9.6 Cytori Therapeutics, Inc.
9.7 Celgene Corporation
9.8 Geron Corporation
9.9 Genzyme Corporation
9.10 Osiris Therapeutics
9.11 Japan Tissue Engineering, Co., Ltd.
9.12 ThermoGenesis Corporation

List of Figures
Figure 5-1: US - Number of People Affected with Degenerative Diseases (Million), 1900 to 2050
Figure 5-2: Global - Regenerative Medicine Market (Billion US$), 2010-2014
Figure 5-3: Global - Regenerative Medicine Companies by Region (%)
Figure 5-4: Global - Tissue Engineered Products Market (Billion US$), 2010-2014
Figure 5-5: Global - Cell Therapy Market (Billion US$), 2010-2014
Figure 6-1: Global - Diabetes Prevalence in Developed and Developing Countries by Age Group (Million), 2010 & 2030
Figure 7-1: US - Regenerative Medicine Market (Billion US$), 2010-2014
Figure 7-2: US - CIRM Funding by Disease (%)
Figure 7-3: Europe - Regenerative Medicine Market (Billion US$), 2010-2014
Figure 7-4: Europe - Regenerative Medicine Companies by Segment (%)
Figure 7-5: Europe - Regenerative Medicine Companies by Country (%)
Figure 7-6: Europe - Share of Disease in Autologous Cellular Therapy (2009)
Figure 7-7: Europe - Share of Disease in Allogeneic Cellular Therapy (2009)
Figure 8-1: Global - Number of Patent Families for Regenerative Medicine by Country (1991-2011)

List of Tables
Table 4-1: Global - R&D Spending by Key Players (Million US$), 2010
Table 4-2: Global - Number of People Aged above 60 Years in Key Countries (Million), 2009
Table 6-1: Stem Cell Characteristics for Cardiac Repair
Table 7-1: US - Potential Patient Population for Cell based Therapies (Million)
Table 7-2: US - Number of Patients Waiting for Organ Transplant
Table 7-3: India - List of Stem Cell Related Projects Funded by Department of Biotechnology
Table 9-1: Bioheart, Inc. - Products under Development
Table 9-2: Geron Corporation - Products under Development

More new market research reports by the publisher can be found at RNCOS E-Services page.



The Market Publishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970